The relative contribution of myelin-specific Th1 and Th17 cells in the pathology of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), is controversial. IL-12, the key cytokine necessary for the differentiation of Th1 cells, has been found to be dispensable for EAE induction; while the related cytokine associated with Th17 cells, IL-23, is a critical factor for inducing EAE. Since EAE is induced by immunization with myelin proteins in CFA which contains M. tuberculosis that generates a prototypical Th1-mediated immune response, we sought to determine if replacing the M. tuberculosis in the adjuvant with a bacterium that induces an IL-23-dependent Th17 cell response during infection would induce EAE with a different phenotype. C. rodentium, a bacterium that requires IL-23 for protective immunity, was used as the adjuvant in EAE and compared to CFA. Mice immunized with C. rodentium adjuvant (CRA) developed classical signs of EAE, similar to CFA-immunized mice, but disease was less severe with a later onset and slower progression than CFA. Surprisingly, the peripheral cytokine profile revealed similar numbers of Th1 and Th17 cells for both CFA and CRA-immunized mice; however, the number of Th1 and Th17 cells was significantly reduced in the CNS of CRA-immunized mice. The development of EAE in CRA-immunized mice was associated with epitope spreading. The unique clinical course of CRA immunizations helps serve as a useful alternative model for studying EAE pathogenesis and potential therapeutics for MS.
Introduction
Experimental autoimmune encephalomyelitis (EAE) has a long history as a model of Multiple Sclerosis (MS), and it has expanded our understanding of inflammatory processes that occur in demyelinating disease. EAE originated from observations over one hundred years ago when individuals immunized with Pasteur's rabies vaccine developed an encephalomyelitis caused by a reaction to the CNS tissue contaminating the inactivated virus. When scientists attempted to replicate the observed encephalomyelitis by injecting animals with homogenized CNS tissue, they had only limited success inducing disease (Baxter, 2007; Mackay and Anderson, 2010) . It was not until Jules Freund introduced an adjuvant containing dried, killed Mycobacterium tuberculosis that disease could be induced consistently in animals, thus establishing the EAE model (Freund et al., 1947; Kabat et al., 1947; Morgan, 1947) . Today EAE induced by immunization with myelin protein emulsified in Complete Freund's Adjuvant (CFA) is one of the most studied immune-mediated diseases and has enhanced our understanding of autoimmunity, as well as fundamental immunologic mechanisms.
Partially spurred by the use of M. tuberculosis in the adjuvant, EAE has long been considered a Th1 disease mediated by T cells secreting key cytokines, such as IFN-γ. This paradigm was called into question with observations that IFN-γ-deficient and IFN-γ receptor-deficient mice remained susceptible to EAE (Ferber et al., 1996; Willenborg et al., 1996) . Since IL-12 is a critical cytokine for the differentiation of Th1 cells, Cua et al. (2003) developed mice deficient for the subunits of IL-12 and a related cytokine, IL-23, and determined if these mice could develop EAE. Mice deficient in the p40 subunit shared by IL-12/IL-23 or the p19 subunit specific for IL-23 were protected from EAE, whereas mice deficient in the IL-12 specific p35 subunit were still susceptible to disease (Cua et al., 2003) . Subsequent papers corroborated this finding demonstrating a critical role of IL-23 in the pathogenesis of EAE (Chen et al., 2006; Thakker et al., 2007; Awasthi et al., 2009) . The mechanism by which IL-23 mediates EAE pathogenesis remains unclear. One mechanism that has gained the most attention has been the observation that IL-23 promotes the production of inflammatory Th17 cells (Langrish et al., 2005) .
Although M. tuberculosis infections generate small amounts of Th17 cytokines, control of infection is dependent on a Th1 response (Cooper et al., 1993 (Cooper et al., , 2002 Khader et al., 2005) . Immunizations with CFA also generate high levels of IFN-γ and other Th1 cytokines (Cua et al., 2003; Langrish et al., 2005) . IL-23 plays a contributory role, but it is not required to limit M. tuberculosis growth (Khader et al., 2005) . On Journal of Neuroimmunology 237 (2011) 33-38 
